Note: Some GLP-1s are not approved for weight loss, but some doctors may prescribe them off-label for this use
Menopause already increases a womans risk of muscle loss (sarcopenia) and bone thinning (osteoporosis), so women using GLP1 medications during this transition should be especially vigilant
Related Articles and Topics: Intermittent Fasting: Benefits from changing Gene Expression References: Alsuwailem, Omar A., et al
The American Heart Association has explicitly supported these medications for mitigating outcomes associated with atherosclerotic cardiovascular disease, including myocardial infarction, stroke, and cardiovascular death (Marx et al
Emerging Trends in Drugs, Addictions, and Health
This is usually the abdomen